Acadia Pharmaceuticals (ACAD) Other Operating Expenses (2015 - 2026)

Acadia Pharmaceuticals' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $24.8 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 21.57% year-over-year to $24.8 million; the TTM figure through Mar 2026 stood at $93.4 million (up 238.92% YoY), while the FY2024 annual figure was $146.5 million, changed N/A from the prior year.
• Other Operating Expenses was $24.8 million for Q1 2026 at Acadia Pharmaceuticals, down from $26.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $26.2 million in Q4 2025 to a low of -$124.7 million in Q4 2024.
• Historically, Other Operating Expenses has averaged $5.9 million across 5 years, with a median of $17.9 million in 2023.
• Biggest YoY gain for Other Operating Expenses was 1276.78% in 2024; the steepest drop was 797.07% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $2.4 million in 2022, then jumped by 641.44% to $17.9 million in 2023, then tumbled by 797.07% to -$124.7 million in 2024, then soared by 121.03% to $26.2 million in 2025, then declined by 5.47% to $24.8 million in 2026.
• The last three Other Operating Expenses figures came in at $24.8 million (Q1 2026), $26.2 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.